Gennex Laboratories Share Price
10.27-0.16 (-1.53%)
-18.56% past 1 Year
Corporate filings & documents
Announcements
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication of AGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Telugu - Local) on September 09 2026 for the 41st Annual General Meeting of the Company to be held on September 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 week agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication of AGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Telugu - Local) on September 09 2026 for the 41st Annual General Meeting of the Company to be held on September 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 week agoWe are pleased to inform that our subsidiary company M/s Deccan Remedies Limited has received approval from the Drugs Control Administration Government of Andhra Pradesh granting License for Manufacturing of additional Products under form 25 and Test License for the purpose of examination test or analysis under Form 29. Approval received from DCA Government of Andhra Pradesh is enclosed herewith for your information and for taking the same on record.
1 week agoWe are pleased to inform that our subsidiary company M/s Deccan Remedies Limited has received approval from the Drugs Control Administration Government of Andhra Pradesh granting License for Manufacturing of additional Products under form 25 and Test License for the purpose of examination test or analysis under Form 29. Approval received from DCA Government of Andhra Pradesh is enclosed herewith for your information and for taking the same on record.
1 week agoWith reference to the subject matter As per the Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby submits 41st Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31 2026 inter alia Notice of the Annual General Meeting to be held on Wednesday September 30 2026 Directors Report Independent Audit Report of Statutory Auditor Financial Statements (Standalone and Consolidated) being Balance Sheet Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31 2026 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e. www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours.This intimation is also being uploaded on the Company website: www.gennexlab.com.
1 week agoWith reference to the subject matter As per the Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby submits 41st Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31 2026 inter alia Notice of the Annual General Meeting to be held on Wednesday September 30 2026 Directors Report Independent Audit Report of Statutory Auditor Financial Statements (Standalone and Consolidated) being Balance Sheet Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31 2026 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e. www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours.This intimation is also being uploaded on the Company website: www.gennexlab.com.
1 week agoPursuant to Regulation 42 of SEBI (LODR) Regulations 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23 2026 to September 30 2026 (both days inclusive) for the purpose of 41sr Annual General Meeting to be held on Wednesday September 30 2026.The intimation is also being uploaded on the Company website i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
2 weeks agoPursuant to Regulation 42 of SEBI (LODR) Regulations 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23 2026 to September 30 2026 (both days inclusive) for the purpose of 41sr Annual General Meeting to be held on Wednesday September 30 2026.The intimation is also being uploaded on the Company website i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
2 weeks ago1. Draft Directors/ Board Report for the Financial Year March 31 2026;2. The 41st Annual General Meeting of the Company to be held on Wednesday September 30 2026 at 12:30 P.M. through (VC/OAVM);3. Appointment of Ms. Sweety Kapoor Practicing Company Secretary Kolkata as Scrutinizer for the AGM;4. Book Closure Date in connection with 41st AGM between September 23 2026 to September 30 2026;5. Appointment of NSDL as authorized agency for facilitating 41st AGM and providing E- Voting facility;6. E-voting period from Sunday September 27 2026 at 9.00 AM to Tuesday September 29 2026 at 5.00 PM with cut-off date September 23 2026;7. Secretarial Audit Report issued by Mr. Md. Tausif Shamim Practicing Company Secretary Kolkata;8. Cost Audit Report issued by M/s. Sai Krishna & Associates Cost Accountants for the year ended March 31 2026;9. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 05:00 PM.
2 weeks ago1. Draft Directors/ Board Report for the Financial Year March 31 2026;2. The 41st Annual General Meeting of the Company to be held on Wednesday September 30 2026 at 12:30 P.M. through (VC/OAVM);3. Appointment of Ms. Sweety Kapoor Practicing Company Secretary Kolkata as Scrutinizer for the AGM;4. Book Closure Date in connection with 41st AGM between September 23 2026 to September 30 2026;5. Appointment of NSDL as authorized agency for facilitating 41st AGM and providing E- Voting facility;6. E-voting period from Sunday September 27 2026 at 9.00 AM to Tuesday September 29 2026 at 5.00 PM with cut-off date September 23 2026;7. Secretarial Audit Report issued by Mr. Md. Tausif Shamim Practicing Company Secretary Kolkata;8. Cost Audit Report issued by M/s. Sai Krishna & Associates Cost Accountants for the year ended March 31 2026;9. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 05:00 PM.
2 weeks agoGennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To decide regarding the conduct of 41st AGM for the year ended March 31 2026;2. To Consider and Appoint Scrutinizer of the 41st Annual General Meeting in case of Finalisation of the Date of AGM;3. Any other business with permission of the Chairperson.
3 weeks agoGennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To decide regarding the conduct of 41st AGM for the year ended March 31 2026;2. To Consider and Appoint Scrutinizer of the 41st Annual General Meeting in case of Finalisation of the Date of AGM;3. Any other business with permission of the Chairperson.
3 weeks agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 announced by the Board of Directors in its meeting held on Friday August 14 2026. Financial results had been published in both Business Standard (English) and Saksham (Telugu - Local) on August 15 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 month agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 announced by the Board of Directors in its meeting held on Friday August 14 2026. Financial results had been published in both Business Standard (English) and Saksham (Telugu - Local) on August 15 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 month agoIn just concluded Meeting of Board of Directors the Board approved and considered the following items:1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended June 30 2026.2. Limited Review Reports from Statutory auditors on Unaudited Standalone and Consolidated Financial Statement for Quarter ended June 30 2026.3. Other itemsWe hereby submit that the meeting had commenced at 4.00 PM and concluded at 4.40 PM.
1 month agoIn just concluded Meeting of Board of Directors the Board approved and considered the following items:1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended June 30 2026.2. Limited Review Reports from Statutory auditors on Unaudited Standalone and Consolidated Financial Statement for Quarter ended June 30 2026.3. Other itemsWe hereby submit that the meeting had commenced at 4.00 PM and concluded at 4.40 PM.
1 month agoIn just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed here with);3. Other Business items. We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 4.40 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
1 month agoIn just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed here with);3. Other Business items. We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 4.40 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
1 month agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday August 14 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 month agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday August 14 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 month agoGennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30 2026; 3. Other Business items.
1 month agoGennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30 2026; 3. Other Business items.
1 month agoWith reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the Quarter ended June 30 2026.We request you to take the above information on record and acknowledge the receipt of the same.
2 months agoWith reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the Quarter ended June 30 2026.We request you to take the above information on record and acknowledge the receipt of the same.
2 months agoNotice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of the Company shall remain closed from July 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Un-audited Standalone and Consolidated Financial Results for the First Quarter ended on June 30 2026 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the Un-audited Standalone and Consolidated Financial Results of the Company for the first quarter ending on June 30 2026 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.We request you to take the above information on record.
2 months agoNotice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of the Company shall remain closed from July 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Un-audited Standalone and Consolidated Financial Results for the First Quarter ended on June 30 2026 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the Un-audited Standalone and Consolidated Financial Results of the Company for the first quarter ending on June 30 2026 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.We request you to take the above information on record.
2 months agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
3 months agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
3 months agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
3 months agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
3 months agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
3 months agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
3 months agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Audited (Standalone and Consolidated) Financial Results for the Quarter and year ended March 31 2026 announced by the Board of Directors in its meeting held on May 30 2026. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on June 01 2026.We request you to take the above information on record and acknowledge receipt of the same.
3 months agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Audited (Standalone and Consolidated) Financial Results for the Quarter and year ended March 31 2026 announced by the Board of Directors in its meeting held on May 30 2026. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on June 01 2026.We request you to take the above information on record and acknowledge receipt of the same.
3 months agoIn just concluded Meeting of Board of Directors the Board approved and considered the following items:1. Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31 2026.2. Auditors Report on audited Standalone and Consolidated Financial Statements for the Quarter and Year ended March 31 2026 issued on dated May 30 2026 along with the Statement on Impact of Audit Qualification (Standalone and Consolidated) are attached herewith.We hereby submit that the Board Meeting had commenced at 4:00 pm and concluded at 7:30 pm.This intimation is also uploaded on the company website www.gennexlab.com
3 months agoIn just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Audited Standalone & Consolidated Financial results for the Quarter & Year Ended March 31 2026;2. Auditors Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31 2026 issued on dated May 30 2026 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached herewith - Annexure I;We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 7.30 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
3 months agoIn just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Audited Standalone & Consolidated Financial results for the Quarter & Year Ended March 31 2026;2. Auditors Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31 2026 issued on dated May 30 2026 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached herewith - Annexure I;We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 7.30 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
3 months agoIn compliance with Regulation 24A of SEBI (LODR) Regulations 2015 Board appointed M/s. Mohammed Tausif Shamim & Co. practicing Company Secretary Kolkata as Secretarial Auditor of the Company for the Financial Year ended March 31 2026. They carried out the Secretarial Audit and submitted the Annual Secretarial Compliance Report with reference to the SEBI circular 27/2019 dated 8th February 2019.We hereby submit the Annual Secretarial Compliance Report issued by the Secretarial Auditor within the timeline allowed by SEBI vide Circular No.2021/556 dated 29th April 2021.We request you to take the above information on record and acknowledge the receipt of the same.
3 months agoIn compliance with Regulation 24A of SEBI (LODR) Regulations 2015 Board appointed M/s. Mohammed Tausif Shamim & Co. practicing Company Secretary Kolkata as Secretarial Auditor of the Company for the Financial Year ended March 31 2026. They carried out the Secretarial Audit and submitted the Annual Secretarial Compliance Report with reference to the SEBI circular 27/2019 dated 8th February 2019.We hereby submit the Annual Secretarial Compliance Report issued by the Secretarial Auditor within the timeline allowed by SEBI vide Circular No.2021/556 dated 29th April 2021.We request you to take the above information on record and acknowledge the receipt of the same.
3 months agoWe refer to your email of 25th May 2026 seeking clarification on your observation regarding significant movement noticed by the Exchange in the price of our company security at your exchange in the recent past.In this regard we wish to confirm that the Company has not made any announcement (including impending announcement) nor shared any information of the significance in public domain which may have bearing on the price / volume behavior which the Exchange has not noted. The price movement is not attributable to any announcement or information shared by the Company but is consistent with normal market behavior driven by varied external factors.However the Company will as a matter of practice disclose any price sensitive information or announcement to the Exchange in compliance with applicable regulations.We therefor reiterate that the significant price movement of our company security on the Exchange is not on account of any information/announcement made by us.
3 months agoWe refer to your email of 25th May 2026 seeking clarification on your observation regarding significant movement noticed by the Exchange in the price of our company security at your exchange in the recent past.In this regard we wish to confirm that the Company has not made any announcement (including impending announcement) nor shared any information of the significance in public domain which may have bearing on the price / volume behavior which the Exchange has not noted. The price movement is not attributable to any announcement or information shared by the Company but is consistent with normal market behavior driven by varied external factors.However the Company will as a matter of practice disclose any price sensitive information or announcement to the Exchange in compliance with applicable regulations.We therefor reiterate that the significant price movement of our company security on the Exchange is not on account of any information/announcement made by us.
3 months agoThe Exchange has sought clarification from Gennex Laboratories Ltd on May 25 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
3 months agoThe Exchange has sought clarification from Gennex Laboratories Ltd on May 25 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
3 months agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please fine enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company Scheduled to be held on Saturday May 30 2026 for Adoption of Audited (Standalone and Consolidated) Financial Results for the Quarter and Year ended March 31 2026 along with the Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Local - Telugu) on May 20 2026.We request you to take the above information on record and acknowledge receipt of the same.
4 months agoPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please fine enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company Scheduled to be held on Saturday May 30 2026 for Adoption of Audited (Standalone and Consolidated) Financial Results for the Quarter and Year ended March 31 2026 along with the Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Local - Telugu) on May 20 2026.We request you to take the above information on record and acknowledge receipt of the same.
4 months agoGennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve With reference to the above captioned subject matter we hereby inform you that the Meeting of Board of Directors of the Company will be held on Saturday May 30 2026 at 04:00 PM at the Corporate Office of the Company inter-alia to consider the following matters: 1. Consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31 2026; 2. Consider the Independent Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the quarter and year ended March 31 2026; 3. Other Business items. Further in continuation to earlier disclosure dated March 25 2026 Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Audited Financial Results for all designated persons their immediate relatives and all connected persons covered under the aforesaid code.This intimation is also being uploaded on the Company website: www.gennexlab.com.
4 months agoGennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve With reference to the above captioned subject matter we hereby inform you that the Meeting of Board of Directors of the Company will be held on Saturday May 30 2026 at 04:00 PM at the Corporate Office of the Company inter-alia to consider the following matters: 1. Consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31 2026; 2. Consider the Independent Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the quarter and year ended March 31 2026; 3. Other Business items. Further in continuation to earlier disclosure dated March 25 2026 Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Audited Financial Results for all designated persons their immediate relatives and all connected persons covered under the aforesaid code.This intimation is also being uploaded on the Company website: www.gennexlab.com.
4 months agoIn compliance to Regulation 44 of SEBI (LODR) Regulations 2015 as amended from time to time (Listing Regulations) please find enclosed herewith voting results of electronic Extraordinary General Meeting of the Company held on May 12 2026 at 12.30 Hrs through VC and OAVM along with the Consolidated Scrutinizers Report.It is to inform that all the resolutions set out in the Notice were duly approved by the Shareholders with requisite majority. The Voting results along with the Scrutinizers Report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
4 months agoIn compliance to Regulation 44 of SEBI (LODR) Regulations 2015 as amended from time to time (Listing Regulations) please find enclosed herewith voting results of electronic Extraordinary General Meeting of the Company held on May 12 2026 at 12.30 Hrs through VC and OAVM along with the Consolidated Scrutinizers Report.It is to inform that all the resolutions set out in the Notice were duly approved by the Shareholders with requisite majority. The Voting results along with the Scrutinizers Report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
4 months agoPursuant to Reg.30 of SEBI (LODR) Regulations 2015 we are pleased to provide hereunder the proceedings of Extraordinary General Meeting (EGM) of the Company held on Tuesday May 12 2026 through video conferencing ("VC") / other audio visual means (OS VM). The meeting was held in compliance to the General Circular No.03/2025 dated September 22 2025 issued by the Ministry of Corporate Affairs (MCA) and Circular No2024/133 dated October 3 2024 issued by SEBI Companies are allowed to hold AGM/EGM through VC / OA VM without the physical presence of members at a common venue till further orders and other applicable provisions of the Companies Act 2013 read with rules made thereunder.The Meeting commenced at 12:30 Hrs and concluded at 01:18 Hrs. All the Statutory Registers and other requisite documents were available electronically during the EGM for inspection by the members.This intimation is also uploaded in the Company website www.gennexlab.com
4 months agoAnnual reports
Concalls & investor presentations
No presentations found